The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Enbrel is a biopharmaceutical that treats autoimmune diseases by interfering with tumor necrosis factor (TNF, a soluble inflammatory cytokine) by acting as a TNF inhibitor.
The global Enbrel market was valued at US$ 8764 million in 2023 and is anticipated to reach US$ 10530 million by 2030, witnessing a CAGR of 2.6% during the forecast period 2024-2030.
The Enbrel market is primarily driven by the demand for effective treatment options for autoimmune diseases. Enbrel (etanercept) is a medication used to treat conditions like rheumatoid arthritis, psoriasis, and ankylosing spondylitis. The increasing prevalence of autoimmune disorders and the growing recognition of their impact on patient quality of life contribute to market growth. Moreover, advancements in biologic therapies and the demonstrated efficacy of Enbrel in reducing disease symptoms further propel adoption. However, challenges include managing the high cost of biologic treatments and addressing potential side effects. Navigating patient access issues, optimizing treatment protocols, and ensuring long-term safety are ongoing concerns. The market's success relies on continuous research in autoimmune disease management, collaborations between pharmaceutical manufacturers and healthcare providers, and comprehensive patient education on the benefits and potential risks of Enbrel treatment while addressing the evolving challenges associated with autoimmune disease treatment access and affordability.
This report aims to provide a comprehensive presentation of the global market for Enbrel, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Enbrel.
Report Scope
The Enbrel market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Enbrel market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Enbrel manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Amgen
Pfizer
3SBIO
Celgen Biopharma
Segment by Type
Brands Drugs
Biosimilar Drugs
Segment by Application
Rheumatoid Arthritis
Juvenile Idiopathic Arthritis
Psoriatic Arthritis
Ankylosing Spondylitis
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Enbrel manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Enbrel in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Enbrel is a biopharmaceutical that treats autoimmune diseases by interfering with tumor necrosis factor (TNF, a soluble inflammatory cytokine) by acting as a TNF inhibitor.
The global Enbrel market was valued at US$ 8764 million in 2023 and is anticipated to reach US$ 10530 million by 2030, witnessing a CAGR of 2.6% during the forecast period 2024-2030.
The Enbrel market is primarily driven by the demand for effective treatment options for autoimmune diseases. Enbrel (etanercept) is a medication used to treat conditions like rheumatoid arthritis, psoriasis, and ankylosing spondylitis. The increasing prevalence of autoimmune disorders and the growing recognition of their impact on patient quality of life contribute to market growth. Moreover, advancements in biologic therapies and the demonstrated efficacy of Enbrel in reducing disease symptoms further propel adoption. However, challenges include managing the high cost of biologic treatments and addressing potential side effects. Navigating patient access issues, optimizing treatment protocols, and ensuring long-term safety are ongoing concerns. The market's success relies on continuous research in autoimmune disease management, collaborations between pharmaceutical manufacturers and healthcare providers, and comprehensive patient education on the benefits and potential risks of Enbrel treatment while addressing the evolving challenges associated with autoimmune disease treatment access and affordability.
This report aims to provide a comprehensive presentation of the global market for Enbrel, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Enbrel.
Report Scope
The Enbrel market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Enbrel market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Enbrel manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Amgen
Pfizer
3SBIO
Celgen Biopharma
Segment by Type
Brands Drugs
Biosimilar Drugs
Segment by Application
Rheumatoid Arthritis
Juvenile Idiopathic Arthritis
Psoriatic Arthritis
Ankylosing Spondylitis
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Enbrel manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Enbrel in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Enbrel Market Overview
1.1 Product Overview and Scope of Enbrel
1.2 Enbrel Segment by Type
1.2.1 Global Enbrel Market Value Comparison by Type (2024-2030)
1.2.2 Brands Drugs
1.2.3 Biosimilar Drugs
1.3 Enbrel Segment by Application
1.3.1 Global Enbrel Market Value by Application: (2024-2030)
1.3.2 Rheumatoid Arthritis
1.3.3 Juvenile Idiopathic Arthritis
1.3.4 Psoriatic Arthritis
1.3.5 Ankylosing Spondylitis
1.3.6 Other
1.4 Global Enbrel Market Size Estimates and Forecasts
1.4.1 Global Enbrel Revenue 2019-2030
1.4.2 Global Enbrel Sales 2019-2030
1.4.3 Global Enbrel Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Enbrel Market Competition by Manufacturers
2.1 Global Enbrel Sales Market Share by Manufacturers (2019-2024)
2.2 Global Enbrel Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Enbrel Average Price by Manufacturers (2019-2024)
2.4 Global Enbrel Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Enbrel, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Enbrel, Product Type & Application
2.7 Enbrel Market Competitive Situation and Trends
2.7.1 Enbrel Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Enbrel Players Market Share by Revenue
2.7.3 Global Enbrel Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Enbrel Retrospective Market Scenario by Region
3.1 Global Enbrel Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Enbrel Global Enbrel Sales by Region: 2019-2030
3.2.1 Global Enbrel Sales by Region: 2019-2024
3.2.2 Global Enbrel Sales by Region: 2025-2030
3.3 Global Enbrel Global Enbrel Revenue by Region: 2019-2030
3.3.1 Global Enbrel Revenue by Region: 2019-2024
3.3.2 Global Enbrel Revenue by Region: 2025-2030
3.4 North America Enbrel Market Facts & Figures by Country
3.4.1 North America Enbrel Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Enbrel Sales by Country (2019-2030)
3.4.3 North America Enbrel Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Enbrel Market Facts & Figures by Country
3.5.1 Europe Enbrel Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Enbrel Sales by Country (2019-2030)
3.5.3 Europe Enbrel Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Enbrel Market Facts & Figures by Country
3.6.1 Asia Pacific Enbrel Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Enbrel Sales by Country (2019-2030)
3.6.3 Asia Pacific Enbrel Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Enbrel Market Facts & Figures by Country
3.7.1 Latin America Enbrel Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Enbrel Sales by Country (2019-2030)
3.7.3 Latin America Enbrel Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Enbrel Market Facts & Figures by Country
3.8.1 Middle East and Africa Enbrel Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Enbrel Sales by Country (2019-2030)
3.8.3 Middle East and Africa Enbrel Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Enbrel Sales by Type (2019-2030)
4.1.1 Global Enbrel Sales by Type (2019-2024)
4.1.2 Global Enbrel Sales by Type (2025-2030)
4.1.3 Global Enbrel Sales Market Share by Type (2019-2030)
4.2 Global Enbrel Revenue by Type (2019-2030)
4.2.1 Global Enbrel Revenue by Type (2019-2024)
4.2.2 Global Enbrel Revenue by Type (2025-2030)
4.2.3 Global Enbrel Revenue Market Share by Type (2019-2030)
4.3 Global Enbrel Price by Type (2019-2030)
5 Segment by Application
5.1 Global Enbrel Sales by Application (2019-2030)
5.1.1 Global Enbrel Sales by Application (2019-2024)
5.1.2 Global Enbrel Sales by Application (2025-2030)
5.1.3 Global Enbrel Sales Market Share by Application (2019-2030)
5.2 Global Enbrel Revenue by Application (2019-2030)
5.2.1 Global Enbrel Revenue by Application (2019-2024)
5.2.2 Global Enbrel Revenue by Application (2025-2030)
5.2.3 Global Enbrel Revenue Market Share by Application (2019-2030)
5.3 Global Enbrel Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Amgen
6.1.1 Amgen Corporation Information
6.1.2 Amgen Description and Business Overview
6.1.3 Amgen Enbrel Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Amgen Enbrel Product Portfolio
6.1.5 Amgen Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Corporation Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Enbrel Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Pfizer Enbrel Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 3SBIO
6.3.1 3SBIO Corporation Information
6.3.2 3SBIO Description and Business Overview
6.3.3 3SBIO Enbrel Sales, Revenue and Gross Margin (2019-2024)
6.3.4 3SBIO Enbrel Product Portfolio
6.3.5 3SBIO Recent Developments/Updates
6.4 Celgen Biopharma
6.4.1 Celgen Biopharma Corporation Information
6.4.2 Celgen Biopharma Description and Business Overview
6.4.3 Celgen Biopharma Enbrel Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Celgen Biopharma Enbrel Product Portfolio
6.4.5 Celgen Biopharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Enbrel Industry Chain Analysis
7.2 Enbrel Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Enbrel Production Mode & Process
7.4 Enbrel Sales and Marketing
7.4.1 Enbrel Sales Channels
7.4.2 Enbrel Distributors
7.5 Enbrel Customers
8 Enbrel Market Dynamics
8.1 Enbrel Industry Trends
8.2 Enbrel Market Drivers
8.3 Enbrel Market Challenges
8.4 Enbrel Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Enbrel Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Enbrel Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Enbrel Market Competitive Situation by Manufacturers in 2023
Table 4. Global Enbrel Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Enbrel Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Enbrel Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Enbrel Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Enbrel Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Enbrel, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Enbrel, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Enbrel, Product Type & Application
Table 12. Global Key Manufacturers of Enbrel, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Enbrel by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Enbrel as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Enbrel Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Enbrel Sales by Region (2019-2024) & (K Units)
Table 18. Global Enbrel Sales Market Share by Region (2019-2024)
Table 19. Global Enbrel Sales by Region (2025-2030) & (K Units)
Table 20. Global Enbrel Sales Market Share by Region (2025-2030)
Table 21. Global Enbrel Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Enbrel Revenue Market Share by Region (2019-2024)
Table 23. Global Enbrel Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Enbrel Revenue Market Share by Region (2025-2030)
Table 25. North America Enbrel Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Enbrel Sales by Country (2019-2024) & (K Units)
Table 27. North America Enbrel Sales by Country (2025-2030) & (K Units)
Table 28. North America Enbrel Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Enbrel Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Enbrel Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Enbrel Sales by Country (2019-2024) & (K Units)
Table 32. Europe Enbrel Sales by Country (2025-2030) & (K Units)
Table 33. Europe Enbrel Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Enbrel Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Enbrel Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Enbrel Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Enbrel Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Enbrel Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Enbrel Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Enbrel Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Enbrel Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Enbrel Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Enbrel Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Enbrel Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Enbrel Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Enbrel Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Enbrel Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Enbrel Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Enbrel Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Enbrel Sales (K Units) by Type (2019-2024)
Table 51. Global Enbrel Sales (K Units) by Type (2025-2030)
Table 52. Global Enbrel Sales Market Share by Type (2019-2024)
Table 53. Global Enbrel Sales Market Share by Type (2025-2030)
Table 54. Global Enbrel Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Enbrel Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Enbrel Revenue Market Share by Type (2019-2024)
Table 57. Global Enbrel Revenue Market Share by Type (2025-2030)
Table 58. Global Enbrel Price (US$/Unit) by Type (2019-2024)
Table 59. Global Enbrel Price (US$/Unit) by Type (2025-2030)
Table 60. Global Enbrel Sales (K Units) by Application (2019-2024)
Table 61. Global Enbrel Sales (K Units) by Application (2025-2030)
Table 62. Global Enbrel Sales Market Share by Application (2019-2024)
Table 63. Global Enbrel Sales Market Share by Application (2025-2030)
Table 64. Global Enbrel Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Enbrel Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Enbrel Revenue Market Share by Application (2019-2024)
Table 67. Global Enbrel Revenue Market Share by Application (2025-2030)
Table 68. Global Enbrel Price (US$/Unit) by Application (2019-2024)
Table 69. Global Enbrel Price (US$/Unit) by Application (2025-2030)
Table 70. Amgen Corporation Information
Table 71. Amgen Description and Business Overview
Table 72. Amgen Enbrel Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Amgen Enbrel Product
Table 74. Amgen Recent Developments/Updates
Table 75. Pfizer Corporation Information
Table 76. Pfizer Description and Business Overview
Table 77. Pfizer Enbrel Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Pfizer Enbrel Product
Table 79. Pfizer Recent Developments/Updates
Table 80. 3SBIO Corporation Information
Table 81. 3SBIO Description and Business Overview
Table 82. 3SBIO Enbrel Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. 3SBIO Enbrel Product
Table 84. 3SBIO Recent Developments/Updates
Table 85. Celgen Biopharma Corporation Information
Table 86. Celgen Biopharma Description and Business Overview
Table 87. Celgen Biopharma Enbrel Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Celgen Biopharma Enbrel Product
Table 89. Celgen Biopharma Recent Developments/Updates
Table 90. Key Raw Materials Lists
Table 91. Raw Materials Key Suppliers Lists
Table 92. Enbrel Distributors List
Table 93. Enbrel Customers List
Table 94. Enbrel Market Trends
Table 95. Enbrel Market Drivers
Table 96. Enbrel Market Challenges
Table 97. Enbrel Market Restraints
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Enbrel
Figure 2. Global Enbrel Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Enbrel Market Share by Type in 2023 & 2030
Figure 4. Brands Drugs Product Picture
Figure 5. Biosimilar Drugs Product Picture
Figure 6. Global Enbrel Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Enbrel Market Share by Application in 2023 & 2030
Figure 8. Rheumatoid Arthritis
Figure 9. Juvenile Idiopathic Arthritis
Figure 10. Psoriatic Arthritis
Figure 11. Ankylosing Spondylitis
Figure 12. Other
Figure 13. Global Enbrel Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Enbrel Market Size (2019-2030) & (US$ Million)
Figure 15. Global Enbrel Sales (2019-2030) & (K Units)
Figure 16. Global Enbrel Average Price (US$/Unit) & (2019-2030)
Figure 17. Enbrel Report Years Considered
Figure 18. Enbrel Sales Share by Manufacturers in 2023
Figure 19. Global Enbrel Revenue Share by Manufacturers in 2023
Figure 20. The Global 5 and 10 Largest Enbrel Players: Market Share by Revenue in 2023
Figure 21. Enbrel Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 22. Global Enbrel Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 23. North America Enbrel Sales Market Share by Country (2019-2030)
Figure 24. North America Enbrel Revenue Market Share by Country (2019-2030)
Figure 25. United States Enbrel Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Canada Enbrel Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. Europe Enbrel Sales Market Share by Country (2019-2030)
Figure 28. Europe Enbrel Revenue Market Share by Country (2019-2030)
Figure 29. Germany Enbrel Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. France Enbrel Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. U.K. Enbrel Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Italy Enbrel Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Russia Enbrel Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Asia Pacific Enbrel Sales Market Share by Region (2019-2030)
Figure 35. Asia Pacific Enbrel Revenue Market Share by Region (2019-2030)
Figure 36. China Enbrel Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Japan Enbrel Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. South Korea Enbrel Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. India Enbrel Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Australia Enbrel Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. China Taiwan Enbrel Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Indonesia Enbrel Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Thailand Enbrel Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Malaysia Enbrel Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Latin America Enbrel Sales Market Share by Country (2019-2030)
Figure 46. Latin America Enbrel Revenue Market Share by Country (2019-2030)
Figure 47. Mexico Enbrel Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Brazil Enbrel Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Argentina Enbrel Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Middle East & Africa Enbrel Sales Market Share by Country (2019-2030)
Figure 51. Middle East & Africa Enbrel Revenue Market Share by Country (2019-2030)
Figure 52. Turkey Enbrel Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Saudi Arabia Enbrel Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. UAE Enbrel Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Global Sales Market Share of Enbrel by Type (2019-2030)
Figure 56. Global Revenue Market Share of Enbrel by Type (2019-2030)
Figure 57. Global Enbrel Price (US$/Unit) by Type (2019-2030)
Figure 58. Global Sales Market Share of Enbrel by Application (2019-2030)
Figure 59. Global Revenue Market Share of Enbrel by Application (2019-2030)
Figure 60. Global Enbrel Price (US$/Unit) by Application (2019-2030)
Figure 61. Enbrel Value Chain
Figure 62. Enbrel Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
